Chun-Shiang Chung Selected Research

Peroxidase (Myeloperoxidase)

1/2021	Survival and Pulmonary Injury After Neonatal Sepsis: PD1/PDL1's Contributions to Mouse and Human Immunopathology.
1/2015	Programmed cell death receptor ligand 1 modulates the regulatory T cells' capacity to repress shock/sepsis-induced indirect acute lung injury by recruiting phosphatase SRC homology region 2 domain-containing phosphatase 1.
4/2010	Therapeutic accessibility of caspase-mediated cell death as a key pathomechanism in indirect acute lung injury.
9/2007	Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury.
12/2002	Shock-induced neutrophil mediated priming for acute lung injury in mice: divergent effects of TLR-4 and TLR-4/FasL deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chun-Shiang Chung Research Topics

Disease

50	Sepsis (Septicemia) 11/2023 - 01/2002
15	Hemorrhage 01/2020 - 12/2002
10	Shock 01/2023 - 01/2003
10	Inflammation (Inflammations) 01/2022 - 04/2003
10	Acute Lung Injury 01/2020 - 04/2003
10	Hemorrhagic Shock 11/2019 - 04/2004
9	Lung Injury 01/2022 - 07/2004
5	Infections 11/2019 - 11/2013
5	Critical Illness (Critically Ill) 01/2018 - 01/2008
4	Septic Shock (Toxic Shock Syndrome) 01/2018 - 04/2009
4	Pneumonia (Pneumonitis) 08/2011 - 04/2003
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023 - 11/2016
2	Coinfection 05/2021 - 03/2015
2	Body Weight (Weight, Body) 04/2008 - 10/2002
1	Arthrogryposis renal dysfunction cholestasis syndrome 01/2023
1	Neoplasms (Cancer) 01/2022
1	Systemic candidiasis 01/2021
1	Pulmonary Edema 01/2021
1	Persistent Infection 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Hypovolemia 11/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Peritonitis 03/2015
1	Gram-Negative Bacterial Infections 03/2015
1	Cross Infection (Nosocomial Infection) 11/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2011
1	Multiple Organ Failure (MODS) 01/2008
1	Necrosis 01/2007

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2005
15	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2005
14	CytokinesIBA 01/2022 - 04/2004
8	Interleukin-6 (Interleukin 6)IBA 01/2023 - 12/2002
7	salicylhydroxamic acid (SHAM)IBA 01/2023 - 10/2002
6	Interleukin-10 (Interleukin 10)IBA 01/2023 - 01/2004
6	ChemokinesIBA 01/2022 - 04/2003
6	LigandsIBA 01/2021 - 08/2011
6	Death Domain ReceptorsIBA 08/2013 - 10/2005
5	Peroxidase (Myeloperoxidase)IBA 01/2021 - 12/2002
4	Peptides (Polypeptides)IBA 01/2021 - 08/2005
4	Biomarkers (Surrogate Marker)IBA 11/2016 - 04/2009
4	Caspase 3 (Caspase-3)IBA 01/2015 - 04/2010
4	Fas Ligand Protein (Fas Ligand)IBA 08/2011 - 01/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2012 - 12/2005
3	CaspasesIBA 04/2010 - 01/2005
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
2	Immune Checkpoint ProteinsIBA 01/2022 - 01/2018
2	Immunologic Factors (Immunomodulators)IBA 01/2021 - 01/2020
2	Monoclonal AntibodiesIBA 01/2020 - 01/2016
2	LipopolysaccharidesIBA 05/2007 - 04/2004
2	InterleukinsIBA 12/2005 - 12/2002
2	Caspase 8 (Caspase-8)IBA 12/2005 - 10/2005
2	Immunoglobulin G (IgG)IBA 08/2005 - 04/2003
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	ChromatinIBA 01/2023
1	AdrenomedullinIBA 01/2023
1	Calcitonin Receptor-Like ProteinIBA 01/2023
1	NitrogenIBA 01/2023
1	Interleukin-33IBA 05/2021
1	chitotriosidaseIBA 01/2021
1	AntibodiesIBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	chitobioseIBA 01/2021
1	VaccinesIBA 01/2020
1	phenylhydrazonopyrazolone sulfonate 1IBA 01/2020
1	Malaria VaccinesIBA 01/2020
1	Vaccine AdjuvantsIBA 01/2020
1	Ringer's LactateIBA 11/2019
1	Phosphates (Orthophosphate)IBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2018
1	N- alpha- benzoyl- N5- (2- chloro- 1- iminoethyl)- L- ornithine amideIBA 01/2017
1	Tight Junction ProteinsIBA 01/2017
1	IceIBA 01/2017
1	Histones (Histone)IBA 01/2017
1	AB103IBA 03/2015
1	Trans-Activators (Trans-Acting Factor)IBA 01/2015
1	SNARE Proteins (SNAREs)IBA 01/2015
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2015
1	Coloring Agents (Dyes)IBA 11/2014
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2013
1	Glycoproteins (Glycoprotein)IBA 03/2013
1	Protein Kinases (Protein Kinase)IBA 11/2012
1	Complementary DNA (cDNA)IBA 11/2012
1	EndotoxinsIBA 11/2012
1	Type I Tumor Necrosis Factor ReceptorsIBA 08/2011
1	BH3 Interacting Domain Death Agonist ProteinIBA 08/2010
1	Caspase 9IBA 08/2010
1	Liposomes (Liposome)IBA 04/2009
1	Clodronic Acid (Clodronate)IBA 04/2009
1	Ethanol (Ethyl Alcohol)IBA 04/2008
1	SteroidsIBA 07/2007
1	Caspase InhibitorsIBA 01/2007
1	PeptidomimeticsIBA 01/2007
1	Interleukin-12 (IL 12)IBA 11/2006

Therapy/Procedure

39	Ligation 11/2023 - 01/2002
37	Punctures 11/2023 - 01/2002
5	Therapeutics 01/2022 - 05/2007
3	Resuscitation 11/2019 - 08/2005
1	Critical Care (Surgical Intensive Care) 05/2021
1	Length of Stay 11/2013
1	Intraperitoneal Injections 05/2007